VERACYTE, INC. (VCYT) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
67/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 10 wins, 2 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q23/3 |
WinVCYT / S&P 82.33% / 15.20% |
WinVCYT / S&P 17.28% / 15.00% |
WinVCYT / S&P 324.24% / 50.40% |
| 2026-Q12/3 |
LoseVCYT / S&P -23.49% / -4.33% |
WinVCYT / S&P 16.91% / 11.30% |
WinVCYT / S&P 163.41% / 27.70% |
| 2025-Q43/3 |
WinVCYT / S&P 22.63% / 2.65% |
WinVCYT / S&P 16.01% / 9.00% |
WinVCYT / S&P 173.33% / 13.40% |
| 2025-Q32/3 |
WinVCYT / S&P 27.01% / 8.12% |
WinVCYT / S&P 16.41% / 4.61% |
LoseVCYT / S&P -371.43% / 13.45% |
| 2025-Q21/3 |
LoseVCYT / S&P -8.84% / 10.94% |
WinVCYT / S&P 19.91% / 4.83% |
LoseVCYT / S&P -144.59% / 10.63% |
| 2025-Q11/3 |
LoseVCYT / S&P -25.13% / -4.27% |
WinVCYT / S&P 23.42% / 4.98% |
LoseVCYT / S&P -144.09% / 10.57% |
| 2024-Q42/3 |
WinVCYT / S&P 16.33% / 2.41% |
WinVCYT / S&P 23.46% / 5.25% |
LoseVCYT / S&P -129.41% / 6.15% |
| 2024-Q32/3 |
WinVCYT / S&P 57.08% / 5.89% |
WinVCYT / S&P 23.95% / 5.89% |
LoseVCYT / S&P -79.71% / 6.11% |
| 2024-Q22/3 |
LoseVCYT / S&P -2.21% / 4.28% |
WinVCYT / S&P 21.59% / 5.38% |
WinVCYT / S&P 85.00% / 5.12% |
| 2024-Q12/3 |
LoseVCYT / S&P -19.45% / 10.56% |
WinVCYT / S&P 20.66% / 5.71% |
WinVCYT / S&P 126.83% / 5.59% |
| 2023-Q43/3 |
WinVCYT / S&P 23.20% / 11.69% |
WinVCYT / S&P 21.76% / 6.81% |
WinVCYT / S&P 104.00% / 7.78% |
| 2023-Q32/3 |
LoseVCYT / S&P -12.33% / -3.27% |
WinVCYT / S&P 21.01% / 7.52% |
WinVCYT / S&P 16.95% / -5.03% |
| 2023-Q22/3 |
WinVCYT / S&P 14.22% / 8.74% |
WinVCYT / S&P 22.46% / 9.50% |
LoseVCYT / S&P -40.30% / -8.57% |
| 2023-Q11/3 |
LoseVCYT / S&P -6.03% / 7.50% |
WinVCYT / S&P 24.17% / 10.77% |
LoseVCYT / S&P -38.81% / -15.69% |
| 2022-Q42/3 |
WinVCYT / S&P 42.95% / 7.56% |
WinVCYT / S&P 35.09% / 11.88% |
LoseVCYT / S&P -55.75% / -17.99% |
| 2022-Q31/3 |
LoseVCYT / S&P -16.58% / -4.88% |
WinVCYT / S&P 51.88% / 13.47% |
LoseVCYT / S&P -47.79% / -1.41% |
| 2022-Q21/3 |
LoseVCYT / S&P -27.82% / -16.10% |
WinVCYT / S&P 70.42% / 13.71% |
LoseVCYT / S&P -33.66% / 11.04% |
| 2022-Q11/3 |
LoseVCYT / S&P -33.08% / -4.60% |
WinVCYT / S&P 103.63% / 15.97% |
LoseVCYT / S&P -39.09% / 42.23% |
| 2021-Q41/3 |
LoseVCYT / S&P -11.30% / 11.03% |
WinVCYT / S&P 86.85% / 15.00% |
LoseVCYT / S&P VCYT unavailable / 96.40% |
| 2021-Q32/3 |
WinVCYT / S&P 16.18% / 0.58% |
WinVCYT / S&P 65.71% / 10.77% |
LoseVCYT / S&P VCYT unavailable / 69.42% |
| 2021-Q21/3 |
LoseVCYT / S&P -25.62% / 8.55% |
WinVCYT / S&P 39.93% / 6.58% |
LoseVCYT / S&P VCYT unavailable / 51.81% |
| 2021-Q12/3 |
WinVCYT / S&P 9.83% / 6.17% |
WinVCYT / S&P 0.90% / -1.06% |
LoseVCYT / S&P VCYT unavailable / 7.39% |
| 2020-Q42/3 |
WinVCYT / S&P 50.63% / 12.15% |
WinVCYT / S&P -2.40% / -3.72% |
LoseVCYT / S&P VCYT unavailable / -33.42% |
| 2020-Q31/3 |
WinVCYT / S&P 25.44% / 8.93% |
LoseVCYT / S&P -3.19% / -2.04% |
LoseVCYT / S&P VCYT unavailable / -27.10% |
| 2020-Q21/3 |
LoseVCYT / S&P 6.54% / 20.54% |
WinVCYT / S&P 3.35% / -0.46% |
LoseVCYT / S&P VCYT unavailable / -27.11% |
| 2020-Q12/3 |
WinVCYT / S&P -12.93% / -19.60% |
WinVCYT / S&P 20.16% / 3.47% |
LoseVCYT / S&P VCYT unavailable / -14.75% |
| 2019-Q42/3 |
WinVCYT / S&P 16.33% / 9.07% |
WinVCYT / S&P 30.82% / 5.36% |
LoseVCYT / S&P VCYT unavailable / 2.99% |
| 2019-Q31/3 |
LoseVCYT / S&P -15.82% / 1.70% |
WinVCYT / S&P 35.57% / 5.02% |
LoseVCYT / S&P VCYT unavailable / 0.21% |
| 2019-Q22/3 |
WinVCYT / S&P 13.95% / 4.30% |
WinVCYT / S&P 36.26% / 6.64% |
LoseVCYT / S&P VCYT unavailable / 8.65% |
| 2019-Q12/3 |
WinVCYT / S&P 98.89% / 13.65% |
WinVCYT / S&P 34.32% / 8.12% |
LoseVCYT / S&P VCYT unavailable / 14.29% |
| 2018-Q42/3 |
WinVCYT / S&P 31.73% / -13.52% |
WinVCYT / S&P 27.87% / 9.05% |
LoseVCYT / S&P VCYT unavailable / 18.23% |
| 2018-Q31/3 |
LoseVCYT / S&P 2.25% / 7.71% |
WinVCYT / S&P 21.58% / 10.21% |
LoseVCYT / S&P VCYT unavailable / 19.06% |
| 2018-Q22/3 |
WinVCYT / S&P 67.99% / 3.43% |
WinVCYT / S&P 11.45% / 9.03% |
LoseVCYT / S&P VCYT unavailable / 14.46% |
| 2018-Q11/3 |
LoseVCYT / S&P -14.85% / -0.76% |
WinVCYT / S&P 11.17% / 7.68% |
LoseVCYT / S&P VCYT unavailable / 12.46% |
| 2017-Q41/3 |
LoseVCYT / S&P -25.54% / 6.64% |
WinVCYT / S&P 10.55% / 7.03% |
LoseVCYT / S&P VCYT unavailable / 13.82% |
| 2017-Q32/3 |
WinVCYT / S&P 5.28% / 4.48% |
WinVCYT / S&P 16.01% / 5.68% |
LoseVCYT / S&P VCYT unavailable / 17.57% |
| 2017-Q21/3 |
LoseVCYT / S&P -9.26% / 3.09% |
WinVCYT / S&P 31.31% / 4.83% |
LoseVCYT / S&P VCYT unavailable / 17.74% |
| 2017-Q12/3 |
WinVCYT / S&P 18.60% / 6.07% |
WinVCYT / S&P 31.12% / 3.67% |
LoseVCYT / S&P VCYT unavailable / 13.32% |
| 2016-Q41/3 |
LoseVCYT / S&P 1.71% / 3.82% |
WinVCYT / S&P 31.48% / 2.09% |
LoseVCYT / S&P VCYT unavailable / 7.05% |
| 2016-Q32/3 |
WinVCYT / S&P 51.29% / 3.85% |
WinVCYT / S&P 27.72% / 0.20% |
LoseVCYT / S&P VCYT unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | VCYT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 49.14% | 20.78% |
| Annualized return | 49.14% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | VCYT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -12.37% | 83.14% |
| Annualized return | -2.61% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | VCYT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 708.04% | 319.30% |
| Annualized return | 23.24% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |